Clincosm LogoSign in Get a demo

recurrent hepatocellular carcinoma

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Hepatocellular Carcinoma, Recurrent Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial (RP3,

Not yet recruiting
  • Locally Advanced Hepatocellular Carcinoma
  • +2 more
  • RP3
  • +2 more
  • (no location specified)
Feb 8, 2023

Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

Recruiting
  • Colorectal Carcinoma
  • +21 more
  • Dual X-ray Absorptiometry
  • +2 more
  • Birmingham, Alabama
  • +18 more
Jan 30, 2023

Recurrent Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage II Hepatocellular Carcinoma AJCC v8 Trial in

Recruiting
  • Recurrent Hepatocellular Carcinoma
  • +3 more
  • Proton Stereotactic Body Radiation Therapy
  • Quality-of-Life Assessment
  • Scottsdale, Arizona
  • +1 more
Jan 5, 2023

BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

Withdrawn
  • BCLC Stage B Hepatocellular Carcinoma
  • +4 more
  • Atezolizumab
  • +3 more
  • (no location specified)
Dec 12, 2022

Recurrent Hepatocellular Carcinoma, Refractory Liver Carcinoma, Stage IV Hepatocellular Carcinoma AJCC v8 Trial in Scottsdale,

Active, not recruiting
  • Recurrent Hepatocellular Carcinoma
  • +4 more
  • Scottsdale, Arizona
  • +2 more
Oct 7, 2022

Child-Pugh Class A, Child-Pugh Class B, Recurrent Hepatocellular Carcinoma Trial in Palo Alto, Sapporo (radiation, procedure,

Active, not recruiting
  • Child-Pugh Class A
  • +2 more
  • Stereotactic Body Radiation Therapy
  • +3 more
  • Palo Alto, California
  • +1 more
Sep 9, 2022

Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type, Metastatic Pancreatic

Active, not recruiting
  • Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
  • +27 more
  • Los Angeles, California
  • +2 more
Aug 5, 2022

Advanced Adult Hepatocellular Carcinoma, Recurrent Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v7 Trial in

Completed
Has Results
  • Advanced Adult Hepatocellular Carcinoma
  • +9 more
  • Doxorubicin Hydrochloride
  • +3 more
  • Birmingham, Alabama
  • +672 more
Aug 3, 2022

Recurrent Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8

Recruiting
  • Recurrent Hepatocellular Carcinoma
  • +7 more
  • Scottsdale, Arizona
  • +1 more
Jun 16, 2022

Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,

Active, not recruiting
  • Adrenal Cortex Carcinoma
  • +39 more
  • Birmingham, Alabama
  • +142 more
May 24, 2022

Recurrent Hepatocellular Carcinoma Trial in Guangzhou (Tislelizumab, Tislelizumab combined with Levatinib)

Recruiting
  • Recurrent Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Mar 31, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Recurrent Hepatocellular Carcinoma Trial in Guangzhou (Sintilimab and Bevacizumab Combined with Radiotherapy)

Recruiting
  • Recurrent Hepatocellular Carcinoma
  • Sintilimab and Bevacizumab Combined with Radiotherapy
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Sep 2, 2021

Recurrent Hepatocellular Carcinoma Trial in Guangzhou (Tislelizumab, Ablation)

Recruiting
  • Recurrent Hepatocellular Carcinoma
  • Guangzhou, Guangdong, China
    Department of Minimally Invasive and Interventional Radiology, L
May 21, 2021

Circulating Tumor Cells As Markers Of Advanced Disease And

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Hepatic resection
  • Monza, MB, Italy
  • +3 more
Mar 12, 2021

Recurrent Hepatocellular Carcinoma Trial in Guangzhou (TCR-T cells)

Unknown status
  • Recurrent Hepatocellular Carcinoma
  • TCR-T cells
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun-Yat Sen University
Dec 16, 2020

Adult Hepatocellular Carcinoma, Recurrent Hepatocellular Carcinoma, Adverse Reaction to Drug Trial in Taoyuan (thalidomine,

Completed
  • Adult Hepatocellular Carcinoma
  • +3 more
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital
Feb 5, 2017

Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Buffalo (biological, other, drug)

Completed
  • Anaplastic Astrocytoma
  • +64 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2016

Recurrent Hepatocellular Carcinoma Trial in Shanghai (TACE, Hepatectomy)

Completed
  • Recurrent Hepatocellular Carcinoma
  • TACE
  • Hepatectomy
  • Shanghai, Shanghai, China
    Eastern hepatobilliary surgery hospital
Mar 30, 2016